USFDA classifies Medgel Pvt Ltd's facility as VAI

The United States Food & Drug Administration (USFDA) had conducted an inspection at the manufacturing facility of Wholly Owned Subsidiary of Medi Caps Ltd i.e., Medgel Private Limited at Pithampur, Madhya Pradesh, from 17th to 21st February, 2025. The company has received a communication from US FDA indicating that the inspection classification of this facility as "Voluntary Action Indicated"(VAI). FDA has concluded that this inspection is "closed" under 21 CFR 20.64 (d) (3).

Shares of MEDI-CAPS LTD. was last trading in BSE at Rs. 43.50 as compared to the previous close of Rs. 44.29. The total number of shares traded during the day was 1549 in over 59 trades.

The stock hit an intraday high of Rs. 44.79 and intraday low of 42.16. The net turnover during the day was Rs. 67742.00.

Source : Equity Bulls

Keywords

MEDICAPS INE442D01010 Pharmaceuticals Medgel USFDA VAI